Our researchers and consultants are valued experts in the field of the pharmaceutical market, pharmacoeconomics and influence of regulatory change on the drug market. . The The 50+ strong PEX PharmaSequence team consists of experts who for years have specialized in all matters relating to the healthcare market. They acquired experience in consulting, market research and pharmaceutical industry, including in management positions
- Physicians and pharmacists
- Mathematicians and statisticians
- Market researchers
- Jarosław FrąckowiakCEO
Managing Partner PhD in sociology ##ypgdhapl.ugprzdlxpz#at#etmeh.ea##
Strategic advisory, SFE, market analysis, forecasting
Expert and co-founder on Polish market of research and SFE services
25 years of involvement in the pharmaceutical market. Jarek was the general manager of Medical Data Management (MDM), Esculap website, and Dendrite. He was also responsible for MDM offices in Czech Republic and Hungary (market research segment), as well as for the Dendrite operation in Russia. Jarek held regional positions too – of general manager for segmentation and profiling services in Europe, later at Cegedim he was responsible for the Cegedim Customer Information CEE operation.
In recent years he served clients with his experience, acting in the role of PharmaExpert's CEO and Deputy CEO of PEX PharmaSequence
- Jakub DalachSales Director, Partner Degree in international relations and management (MBA) ##ypzjq.spaprw#at#etmeh.ea##
Advisory in sales and effectiveness management
Experience in pharmaceutical and consulting companies
Jakub Dalach has many years of experience in the pharmaceutical market. He worked in management positions both in pharmaceutical companies – Polpharma, Ratiopharm, as well as in companies specializing in market research and consulting in healthcare – PMM, MDM, PharmaExpert. He is an expert in sales management, building and implementing business effectives strategies and analysis and use of market data.
Since 2008 Jakub has worked in PharmaExpert, where he focused on development and sale of pharmacy services for the pharmaceutical market. He co-created the first sales force effectiveness specialized units in the pharmaceutical market and was responsible for the design of the first data warehouse in the Polish drug market.
- Tomasz KornackiConsulting and Analysis Department Director
Partner Medical doctor, MBA (University of Illinois) ##idbpho.zdgcprzx#at#etmeh.ea##
Strategic advisory, Business restructuring, M&A, SFE
More than 25 years of experience on higher managerial positions in pharmaceutical companies. Gained fundamental sales and marketing knowledge in companies like Sandoz, MSD, Roche and Wyeth. Acted as general manager in Parke Davis (Pfizer), Polfa Kutno, Teva, Polfarmex and regional in IPSEN. Has extended managerial experience in both Rx and Non-Rx, as well as in business optimisation and restructuring.